| Year |
Title |
Altmetric |
| 2023
|
DOCK2 Mutation and Recurrent Hemophagocytic Lymphohistiocytosis.
Life.
13.
2023
|
|
| 2023
|
Immunologic prediction of long COVID.
Nature Immunology.
24:207-208.
2023
|
|
| 2023
|
Cytokine Storm Syndrome.
Annual Review of Medicine.
74:321-337.
2023
|
|
| 2023
|
Double-barrel targeting of IFN-γ to treat hemophagocytic lymphohistiocytosis.
Journal of Allergy and Clinical Immunology.
151:106-107.
2023
|
|
| 2023
|
Management of Orofacial Manifestations of Juvenile Idiopathic Arthritis: Interdisciplinary Consensus-Based Recommendations.
Arthritis and Rheumatology.
75:4-14.
2023
|
|
| 2023
|
Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Journal of Rheumatology.
50:98-106.
2023
|
|
| 2023
|
Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus.
Clinical and Experimental Rheumatology.
41:186-194.
2023
|
|
| 2022
|
Timely Resolution of SARS-CoV-2-Related Multi-System Inflammatory Syndrome in Children.
Viruses.
15.
2022
|
|
| 2022
|
Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry
2022
|
|
| 2022
|
Placeholder TextIntraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
2022
|
|
| 2022
|
Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis
2022
|
|
| 2022
|
Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children.
Current Opinion in Rheumatology.
34:274-279.
2022
|
|
| 2022
|
Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis.
Frontiers in Pediatrics.
10.
2022
|
|
| 2022
|
Therapeutic strategies for treating juvenile idiopathic arthritis.
Current Opinion in Pharmacology.
64.
2022
|
|
| 2022
|
A 3D CBCT Analysis of Airway and Cephalometric Values in Patients Diagnosed with Juvenile Idiopathic Arthritis Compared to a Control Group.
Applied Sciences.
12.
2022
|
|
| 2022
|
No perfect therapy for the imperfect COVID-19 cytokine storm.
Lancet Rheumatology.
4:e308-e310.
2022
|
|
| 2022
|
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
Arthritis and Rheumatology.
74:570-585.
2022
|
|
| 2022
|
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
Arthritis Care and Research.
74:505-520.
2022
|
|
| 2022
|
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
Arthritis and Rheumatology.
74:553-569.
2022
|
|
| 2022
|
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
Arthritis Care and Research.
74:521-537.
2022
|
|
| 2022
|
Response to: 'Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease' by Sato et al.
Annals of the Rheumatic Diseases.
81:E62.
2022
|
|
| 2022
|
Comparison of the condyle-fossa relationship and resorption between patients with and without Juvenile Idiopathic Arthritis (JIA).
Journal of oral surgery, anesthesia, and hospital dental service.
80:422-430.
2022
|
|
| 2022
|
Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children.
Biology.
11.
2022
|
|
| 2022
|
A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm Syndrome.
Life.
12.
2022
|
|
| 2022
|
Discrete Choice Experiment on a Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.
Arthritis Care and Research.
74:308-316.
2022
|
|
| 2022
|
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.
Arthritis and Rheumatology.
74:263-273.
2022
|
|
| 2022
|
Childhood-onset lupus nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-term kidney status and variation in care.
Arthritis Care and Research.
2022
|
|
| 2022
|
Disease Recapture Rates After Medication Discontinuation and Flare in JIA: An Observational Study within the Childhood Arthritis and Rheumatology Research Alliance Registry.
Arthritis Care and Research.
2022
|
|
| 2022
|
To Wean or Not to Wean: That is the Question.
Arthritis Care and Research.
2022
|
|
| 2022
|
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?.
Current Rheumatology Reports.
24.
2022
|
|
| 2022
|
Who, what, and when—effective therapy for severe COVID-19.
Lancet Rheumatology.
4:e2-e3.
2022
|
|
| 2021
|
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis
2021
|
|
| 2021
|
Distinguishing active pediatric COVID-19 pneumonia from MIS-C
2021
|
|
| 2021
|
Down Syndrome–Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes.
Arthritis Care and Research.
73:1739-1745.
2021
|
|
| 2021
|
Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children.
Current Opinion in Pediatrics.
33:549-555.
2021
|
|
| 2021
|
Impact of the Season of Birth on the Development of Juvenile Idiopathic Arthritis in the United States: A Nationwide Registry-based Study.
Journal of Rheumatology.
48.
2021
|
|
| 2021
|
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
2021
|
|
| 2021
|
Performance of Cytokine Storm Syndrome Scoring Systems in Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children.
ACR Open Rheumatology.
3:820-826.
2021
|
|
| 2021
|
Precision medicine in juvenile idiopathic arthritis—has the time arrived?.
Lancet Rheumatology.
3:e808-e817.
2021
|
|
| 2021
|
Calming the cytokine storm in COVID-19.
Nature Medicine.
27:1674-1675.
2021
|
|
| 2021
|
Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study.
Arthritis and Rheumatology.
73:1910-1920.
2021
|
|
| 2021
|
Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
Arthritis and Rheumatology.
73:1898-1909.
2021
|
|
| 2021
|
Hyperferritinemia wins again: Defining macrophage activation syndrome in pediatric systemic lupus erythematosus.
Journal of Rheumatology.
48:1355-1357.
2021
|
|
| 2021
|
Biologic switching among nonsystemic juvenile idiopathic arthritis patients: A cohort study in the childhood arthritis and rheumatology research alliance registry.
Journal of Rheumatology.
48:1322-1329.
2021
|
|
| 2021
|
Drs. Cron and Chatham reply.
Journal of Rheumatology.
48:1345-1346.
2021
|
|
| 2021
|
Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients.
Journal of Pediatrics.
235:196-202.
2021
|
|
| 2021
|
A perspective on the potential detrimental role of inflammation in pig orthotopic heart xenotransplantation.
Xenotransplantation.
28.
2021
|
|
| 2021
|
Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA–B27, and Equal Sex Representation in Sacroiliitis.
Arthritis Care and Research.
73:940-946.
2021
|
|
| 2021
|
Effect of COVID-19 on anakinra-induced remission in homozygous STX11 hemophagocytosis lymphohistiocytosis.
Pediatric Blood and Cancer.
68.
2021
|
|
| 2021
|
Management of juvenile idiopathic arthritis: Preliminary qualitative findings from the National Dental Practice-Based Research Network.
Journal of the World Federation of Orthodontists.
10:70-73.
2021
|
|
| 2021
|
The role of antirheumatics in patients with COVID-19.
Lancet Rheumatology.
3:e447-e459.
2021
|
|
| 2021
|
COVID-19 cytokine storm: targeting the appropriate cytokine.
Lancet Rheumatology.
3:e236-e237.
2021
|
|
| 2021
|
Recent progress in the treatment of non-systemic juvenile idiopathic arthritis.
2021
|
|
| 2020
|
Defining the scourge of COVID-19 hyperinflammatory syndrome.
Lancet Rheumatology.
2:e727-e729.
2020
|
|
| 2020
|
Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients.
Journal of the Pediatric Infectious Diseases Society.
9:716-737.
2020
|
|
| 2020
|
Drs. cron and chatham reply.
Journal of Rheumatology.
47:1723.
2020
|
|
| 2020
|
Highways to hell: Mechanism-based management of cytokine storm syndromes.
Journal of Allergy and Clinical Immunology.
146:949-959.
2020
|
|
| 2020
|
The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Pediatric Blood and Cancer.
67.
2020
|
|
| 2020
|
Drs. Cron and Chatham reply.
Journal of Rheumatology.
47:1590-1591.
2020
|
|
| 2020
|
Intravenous anakinra for cytokine storm syndromes – Authors' reply.
Lancet Rheumatology.
2:e522-e523.
2020
|
|
| 2020
|
One-two punch of cytokine storm syndrome.
Blood.
136:645-646.
2020
|
|
| 2020
|
Coronavirus is the trigger, but the immune response is deadly.
Lancet Rheumatology.
2:e370-e371.
2020
|
|
| 2020
|
On the Alert for Cytokine Storm: Immunopathology in COVID-19.
Arthritis and Rheumatology.
72:1059-1063.
2020
|
|
| 2020
|
Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome.
Lancet Rheumatology.
2:e358-e367.
2020
|
|
| 2020
|
The Rheumatologist's Role in COVID-19.
Journal of Rheumatology.
47:639-642.
2020
|
|
| 2020
|
The genetics of macrophage activation syndrome.
Genes and Immunity.
21:169-181.
2020
|
|
| 2020
|
Alagille Syndrome and Chronic Arthritis: An International Case Series.
Journal of Pediatrics.
218:228-230.e1.
2020
|
|
| 2020
|
Adolescent Sjogren's syndrome presenting as psychosis: A case series
2020
|
|
| 2020
|
Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Arthritis and Rheumatology.
72:326-334.
2020
|
|
| 2020
|
Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.
Pediatric Drugs.
22:29-44.
2020
|
|
| 2020
|
Severe neonatal coronavirus disease 2019 presenting as acute respiratory distress syndrome
2020
|
|
| 2019
|
Characteristics of coexisting localized scleroderma and inflammatory arthritis..
European Journal of Rheumatology.
7:1-5.
2019
|
|
| 2019
|
Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg..
European Journal of Rheumatology.
7:1-8.
2019
|
|
| 2019
|
Successful treatment of pediatric Tolosa-Hunt syndrome with adalimumab..
European Journal of Rheumatology.
7:1-3.
2019
|
|
| 2019
|
Patterns of B Cell Repletion Following Rituximab Therapy in a Pediatric Rheumatology Cohort.
ACR Open Rheumatology.
1:527-532.
2019
|
|
| 2019
|
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.
Arthritis Care and Research.
71:579-590.
2019
|
|
| 2019
|
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Arthritis and Rheumatology.
71:451-459.
2019
|
|
| 2019
|
Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis.
Genes and Immunity.
20:158-166.
2019
|
|
| 2019
|
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Annals of the Rheumatic Diseases.
78:1357-1362.
2019
|
|
| 2019
|
Emergent high fatality lung disease in systemic juvenile arthritis.
Annals of the Rheumatic Diseases.
78:1722-1731.
2019
|
|
| 2019
|
Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.
ACR Open Rheumatology.
1:345-349.
2019
|
|
| 2019
|
Standardizing terminology and assessment for orofacial conditions in juvenile idiopathic arthritis: International, multidisciplinary consensus-based recommendations.
Journal of Rheumatology.
46:518-522.
2019
|
|
| 2019
|
The immunology of macrophage activation syndrome.
Frontiers in Immunology.
10.
2019
|
|
| 2018
|
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature
2018
|
|
| 2018
|
Risk factors for intraarticular heterotopic bone formation in the temporomandibular joint in Juvenile idiopathic arthritis.
Journal of Rheumatology.
45:1301-1307.
2018
|
|
| 2018
|
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Arthritis and Rheumatology.
70:1508-1518.
2018
|
|
| 2018
|
Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.
Arthritis and Rheumatology.
70:963-970.
2018
|
|
| 2018
|
Toward Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.
Arthritis Care and Research.
70:758-767.
2018
|
|
| 2018
|
Effectiveness and safety of tofacitinib in rheumatoid arthritis: A cohort study.
Arthritis Research and Therapy.
20.
2018
|
|
| 2018
|
Pediatric rheumatology infusion center: Report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year
2018
|
|
| 2018
|
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
Arthritis Care and Research.
70:409-419.
2018
|
|
| 2018
|
Regulatory CD4 T cells inhibit HIV-1 expression of other CD4 T cell subsets via interactions with cell surface regulatory proteins.
Virology.
516:21-29.
2018
|
|
| 2018
|
Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus.
Journal of Rheumatology.
45:393-396.
2018
|
|
| 2018
|
Age and fecal microbial strain-specific differences in patients with spondyloarthritis.
Arthritis Research and Therapy.
20.
2018
|
|
| 2018
|
Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: A comparative study of children with and without juvenile idiopathic arthritis
2018
|
|
| 2018
|
Creating the Subspecialty Pediatrics Investigator Network.
Journal of Pediatrics.
192:3-4.e2.
2018
|
|
| 2018
|
Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?
2018
|
|
| 2017
|
Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: A retrospective study
2017
|
|
| 2017
|
Isolated arthritis of the temporomandibular joint as the initial manifestation of juvenile idiopathic arthritis.
Journal of Rheumatology.
44:1632-1635.
2017
|
|
| 2017
|
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
Journal of Pediatrics.
189:72-78.e3.
2017
|
|
| 2017
|
Malignancy in pediatric-onset systemic lupus erythematosus.
Journal of Rheumatology.
44:1484-1486.
2017
|
|
| 2017
|
Association of Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
Arthritis Care and Research.
69:1088-1094.
2017
|
|
| 2017
|
Weathering a macrophage storm.
Journal of Rheumatology.
44:970-972.
2017
|
|
| 2017
|
A review on SLE and malignancy.
Best Practice and Research: Clinical Rheumatology.
31:373-396.
2017
|
|
| 2017
|
CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.
Virology.
504:79-87.
2017
|
|
| 2017
|
Clinical orofacial examination in juvenile idiopathic arthritis: International consensus-based recommendations for monitoring patients in clinical practice and research studies.
Journal of Rheumatology.
44:326-333.
2017
|
|
| 2016
|
Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors.
Genes and Immunity.
17:400-405.
2016
|
|
| 2016
|
The microbiota in pediatric rheumatic disease: Epiphenomenon or therapeutic target?.
Current Opinion in Rheumatology.
28:537-543.
2016
|
|
| 2016
|
Ustekinumab as a Therapeutic Option for Children with Refractory Enthesitis-Related Arthritis
2016
|
|
| 2016
|
Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza.
Journal of Infectious Diseases.
213:1180-1188.
2016
|
|
| 2016
|
A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis.
Journal of Immunology.
196:2492-2503.
2016
|
|
| 2016
|
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Arthritis and Rheumatology.
68:566-576.
2016
|
|
| 2016
|
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative.
Annals of the Rheumatic Diseases.
75:481-489.
2016
|
|
| 2016
|
Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset with Disease Course in Juvenile Myositis.
Arthritis and Rheumatology.
68:761-768.
2016
|
|
| 2016
|
Interleukin-1 Receptor Blockade Is Associated with Reduced Mortality in Sepsis Patients with Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial∗.
Critical Care Medicine.
44:275-281.
2016
|
|
| 2016
|
Development of spondyloarthropathy following episodes of macrophage activation syndrome in children with heterozygous mutations in haemophagocytic lymphohistiocytosis-associated genes.
Clinical and Experimental Rheumatology.
34:953.
2016
|
|
| 2016
|
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
RMD Open.
2.
2016
|
|
| 2015
|
Magnetic resonance imaging findings following intraarticular infliximab therapy for refractory temporomandibular joint arthritis among children with juvenile idiopathic arthritis.
Journal of Rheumatology.
42:2155-2159.
2015
|
|
| 2015
|
Macrophage Activation Syndrome
2015
|
|
| 2015
|
Clinical features and correct diagnosis of macrophage activation syndrome.
Expert Review of Clinical Immunology.
11:1043-1053.
2015
|
|
| 2015
|
What investigations are needed to optimally monitor for malignancies in SLE?.
Lupus.
24:781-787.
2015
|
|
| 2015
|
Does viral hemorrhagic fever represent reactive hemophagocytic syndrome?.
Journal of Rheumatology.
42:1078-1080.
2015
|
|
| 2015
|
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Journal of Rheumatology.
42:994-1001.
2015
|
|
| 2015
|
Kill or be killed.
Journal of Immunology.
194:5041-5043.
2015
|
|
| 2015
|
Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.
Journal of Rheumatology.
42:541-546.
2015
|
|
| 2015
|
Systemic and intra-articular anti-inflammatory therapy of temporomandibular joint arthritis in children with juvenile idiopathic arthritis.
Seminars in Orthodontics.
21:125-133.
2015
|
|
| 2015
|
Temporomandibular joint arthritis in juvenile idiopathic arthritis: The last frontier.
International Journal of Clinical Rheumatology.
10:273-285.
2015
|
|
| 2014
|
Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis.
Arthritis Research and Therapy.
16.
2014
|
|
| 2014
|
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients.
Arthritis and Rheumatology.
66:3160-3169.
2014
|
|
| 2014
|
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Arthritis and Rheumatology.
66:2871-2880.
2014
|
|
| 2014
|
Genetic Defects in Cytolysis in Macrophage Activation Syndrome.
Current Rheumatology Reports.
16.
2014
|
|
| 2014
|
High dose anakinra for treatment of severe neonatal Kawasaki disease: A case report
2014
|
|
| 2014
|
Treatment of juvenile idiopathic arthritis: A revolution in care
2014
|
|
| 2014
|
Results of a multinational survey regarding the diagnosis and treatment of temporomandibular joint involvement in juvenile idiopathic arthritis
2014
|
|
| 2014
|
Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.
Journal of Rheumatology.
41:113-118.
2014
|
|
| 2014
|
IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter.
Genes and Immunity.
15:137-144.
2014
|
|
| 2014
|
Imaging of the temporomandibular joint in juvenile idiopathic arthritis.
Arthritis Care and Research.
66:47-54.
2014
|
|
| 2014
|
Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.
Journal of Virology.
88:364-376.
2014
|
|
| 2014
|
Systemic lupus erythematosus and malignancies: A review article.
Rheumatic Disease Clinics of North America.
40:497-506.
2014
|
|
| 2014
|
The impact of Nucleofection® on the activation state of primary human CD4 T cells.
Immunotechnology : an international journal of immunological engineering.
408:123-131.
2014
|
|
| 2013
|
Cancer risk in childhood-onset systemic lupus.
Arthritis Research and Therapy.
15.
2013
|
|
| 2013
|
Treatment of Juvenile Idiopathic Arthritis in the Biologic Age.
Rheumatic Disease Clinics of North America.
39:751-766.
2013
|
|
| 2013
|
High doses of infliximab in the management of juvenile idiopathic arthritis.
Journal of Rheumatology.
40:1749-1755.
2013
|
|
| 2013
|
MHCII is required for α-Synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration
2013
|
|
| 2013
|
Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: A case report
2013
|
|
| 2013
|
Condylar Degeneration and Diseases-Local and Systemic Etiologies.
Seminars in Orthodontics.
19:89-96.
2013
|
|
| 2013
|
Higher-dose anakinra is effective in a case of medically refractory macrophage activation syndrome.
Journal of Rheumatology.
40:743-744.
2013
|
|
| 2013
|
Anaphylaxis to etanercept in two children with juvenile idiopathic arthritis
2013
|
|
| 2013
|
Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: A retrospective study.
Rheumatology.
52:554-559.
2013
|
|
| 2013
|
An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.
Journal of Virology.
87:2264-2277.
2013
|
|
| 2012
|
Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells.
Journal of Immunology.
189:2746-2757.
2012
|
|
| 2012
|
Intensive care requirement, rather than degree of serum ferritin elevation, predicts mortality in macrophage activation syndrome.
Pediatric Critical Care Medicine.
13:616.
2012
|
|
| 2012
|
Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis.
Journal of Rheumatology.
39:1880-1887.
2012
|
|
| 2012
|
Management of temporomandibular joint arthritis in adult rheumatology practices: a survey of adult rheumatologists
2012
|
|
| 2012
|
Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis.
Journal of oral surgery, anesthesia, and hospital dental service.
70:1802-1807.
2012
|
|
| 2012
|
Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: Diagnosis, genetics, pathophysiology and treatment.
Genes and Immunity.
13:289-298.
2012
|
|
| 2012
|
NF-ATc1 levels are increased in murine and human lupus T cells: Comment on the article by kyttaris et al.
Arthritis and Rheumatism.
64:1294.
2012
|
|
| 2011
|
Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: Enthesitis-related arthritis predicts persistent active disease.
Journal of Rheumatology.
38:2675-2681.
2011
|
|
| 2011
|
Temporomandibular joint arthritis in pediatric Sjögren disease and sarcoidosis.
Journal of Rheumatology.
38:2272-2273.
2011
|
|
| 2011
|
Reply.
Arthritis Care and Research.
63:1355.
2011
|
|
| 2011
|
High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort
2011
|
|
| 2011
|
Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports
2011
|
|
| 2011
|
1.5 Decades Later: Bearing fruits from the ACR/EULAR exchange Program
2011
|
|
| 2011
|
An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Journal of Rheumatology.
38:764-768.
2011
|
|
| 2011
|
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series.
Arthritis and Rheumatism.
63:545-555.
2011
|
|
| 2011
|
Corticosteroid-induced spinal epidural lipomatosis in the pediatric age group: Report of a new case and updated analysis of the literature
2011
|
|
| 2011
|
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: Case series with 12 patients.
Rheumatology.
50:417-419.
2011
|
|
| 2011
|
Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: Case report and a review of the pediatric autoimmune pancreatitis literature
2011
|
|
| 2011
|
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features..
Arthritis Care and Research.
63:465-482.
2011
|
|
| 2011
|
Combination therapy of abatacept and in children with refractory systemic juvenile idiopathic arthritis: A retrospective case series.
Journal of Rheumatology.
38:180-181.
2011
|
|
| 2010
|
Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
2010
|
|
| 2010
|
Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.
Arthritis and Rheumatism.
62:2499-2509.
2010
|
|
| 2010
|
Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: Comparison of 2 initial dosing regimens.
Journal of Rheumatology.
37:870-875.
2010
|
|
| 2009
|
FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression.
Journal of Immunology.
183:907-915.
2009
|
|
| 2009
|
Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura.
Journal of Pediatrics.
155:136-139.
2009
|
|
| 2009
|
The temporomandibular joint in juvenile idiopathic arthritis: Frequently used and frequently arthritic
2009
|
|
| 2009
|
Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency.
Journal of Virology.
83:3078-3093.
2009
|
|
| 2009
|
Rheumatology fellows' perception on training and careers in academia: The american college of rheumatology fellow research and academic training survey.
Arthritis and Rheumatism.
61:266-273.
2009
|
|
| 2008
|
FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity.
Virology.
381:161-167.
2008
|
|
| 2008
|
A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter.
Genes and Immunity.
9:640-649.
2008
|
|
| 2008
|
High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by ultrasound.
Arthritis and Rheumatism.
58:1189-1196.
2008
|
|
| 2008
|
Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus
2008
|
|
| 2008
|
Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: Data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).
Journal of Rheumatology.
35:343-348.
2008
|
|
| 2008
|
Neither cell-surface nor soluble CD154 levels are associated with coronary artery disease in systemic lupus erythematosus.
Journal of Rheumatology.
35:359-360.
2008
|
|
| 2007
|
Pediatric rheumatology for the adult rheumatologist II: Uveitis in juvenile idiopathic arthritis
2007
|
|
| 2007
|
Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis
2007
|
|
| 2007
|
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
Journal of Rheumatology.
34:1133-1138.
2007
|
|
| 2007
|
Reactive arthritis of the temporomandibular joints and cervical spine in a child
2007
|
|
| 2007
|
CT-guided percutaneous steroid injection for management of inflammatory arthropathy of the temporomandibular joint in children.
American Journal of Roentgenology.
188:182-186.
2007
|
|
| 2007
|
Juvenile idiopathic arthritis classification criteria: Loopholes and diagnosis software [3].
Journal of Rheumatology.
34:234.
2007
|
|
| 2006
|
Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis.
Journal of Rheumatology.
33:2330-2336.
2006
|
|
| 2006
|
Picture of the month: anaplastic large cell lymphoma with hemophagocytic lymphohistiocytosis..
JAMA Pediatrics.
160:1177-1179.
2006
|
|
| 2006
|
Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis.
Journal of Rheumatology.
33:2081-2084.
2006
|
|
| 2006
|
Sjögren syndrome in a child: Favorable response of the arthritis to TNFα blockade.
Clinical Rheumatology.
25:746-748.
2006
|
|
| 2006
|
Temporomandibular joint arthritis in juvenile idiopathic arthritis: The forgotten joint.
Current Opinion in Rheumatology.
18:490-495.
2006
|
|
| 2006
|
Chronic arthritis without uveitis in velocardiofacial syndrome.
Journal of Pediatrics.
149:281.
2006
|
|
| 2006
|
Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Arthritis and Rheumatism.
54:2220-2227.
2006
|
|
| 2006
|
Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
Immunotechnology : an international journal of immunological engineering.
312:1-11.
2006
|
|
| 2006
|
Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-α therapy [1].
Journal of Rheumatology.
33:825.
2006
|
|
| 2006
|
Treatment of pediatric localized scleroderma with methotrexate.
Journal of Rheumatology.
33:609-614.
2006
|
|
| 2006
|
The γc-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.
Virology.
344:283-291.
2006
|
|
| 2006
|
Early growth response-1 is required for CD154 transcription.
Journal of Immunology.
176:811-818.
2006
|
|
| 2006
|
NFAT transcription factors - New players in the pathogenesis of inflammatory arthropathies?.
Autoimmunity Reviews.
5:106-110.
2006
|
|
| 2006
|
Picture of the month
2006
|
|
| 2006
|
The spectrum of renal tubular acidosis in paediatric Sjögren syndrome.
Rheumatology.
45:85-91.
2006
|
|
| 2005
|
Sweet syndrome as an initial presentation in a child with systemic lupus erythematosus [1].
Lupus.
14:974-975.
2005
|
|
| 2005
|
Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis.
Arthritis and Rheumatism.
52:3563-3569.
2005
|
|
| 2005
|
Editorial: A signal achievement in the treatment of arthritis.
Arthritis and Rheumatism.
52:2229-2232.
2005
|
|
| 2005
|
Pediatric rheumatology for the adult rheumatologist I: Therapy and dosing for pediatric rheumatic disorders
2005
|
|
| 2004
|
Reciprocal regulation of the nuclear factor of activated T cells and HIV-1.
Genes and Immunity.
5:158-167.
2004
|
|
| 2004
|
Overexpression of octamer transcription factors 1 or 2 alone has no effect on HIV-1 transcription in primary human CD4 T cells.
Virology.
321:323-331.
2004
|
|
| 2003
|
Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cells activation.
International Immunology.
15:1461-1472.
2003
|
|
| 2003
|
Methotrexate used as a steroid-sparing agent in non-renal chronic Henoch-Schönlein purpura.
Clinical and Experimental Rheumatology.
21:767-769.
2003
|
|
| 2003
|
Erratum: Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression (Molecular and Cellular Biology (2003) 23:2 (510-525)).
Molecular and Cellular Biology.
23:6338.
2003
|
|
| 2003
|
CD154 transcriptional regulation in primary human CD4 T cells.
Immunologic Research.
27:185-202.
2003
|
|
| 2003
|
Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression.
Molecular and Cellular Biology.
23:510-525.
2003
|
|
| 2002
|
Current treatment for chronic arthritis in childhood.
Current Opinion in Pediatrics.
14:684-687.
2002
|
|
| 2002
|
Regulation of the murine Nfatc1 gene by NFATc2.
Journal of Biological Chemistry.
277:10704-10711.
2002
|
|
| 2002
|
HIV-1, NFAT, and cyclosporin: Immunosuppression for the immunosuppressed?.
DNA and Cell Biology.
20:761-767.
2002
|
|
| 2002
|
A T cell-specific enhancer of the human CD40 ligand gene.
Journal of Biological Chemistry.
277:7386-7395.
2002
|
|
| 2001
|
Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells.
Genes and Immunity.
2:464-468.
2001
|
|
| 2001
|
Treatment for JRA in the new millennium
2001
|
|
| 2000
|
Nabumetone induced pseudoporphyria in childhood [3] (multiple letters).
Journal of Rheumatology.
27:1817-1818.
2000
|
|
| 2000
|
Nabumetone induced pseudoporphyria in childhood..
Journal of Rheumatology.
27:1817-1818.
2000
|
|
| 2000
|
NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
Clinical Immunology.
94:179-191.
2000
|
|
| 1999
|
Current treatment by United States and Canadian pediatric rheumatologists.
Journal of Rheumatology.
26:2036-2038.
1999
|
|
| 1999
|
T cell priming enhances IL-4 gene expression by increasing nuclear factor of activated T cells.
Journal of Immunology.
162:860-870.
1999
|
|
| 1998
|
Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis.
Journal of Pediatrics.
132:901-902.
1998
|
|
| 1997
|
Childhood sarcoidosis--does age of onset predict clinical manifestations?.
Journal of Rheumatology.
24:1654-1656.
1997
|
|
| 1997
|
Consistent transient transfection of DNA into non-transformed human and murine T-lymphocytes.
Immunotechnology : an international journal of immunological engineering.
205:145-150.
1997
|
|
| 1997
|
Reactive arthritis to Clostridium difficile in a child.
The Western journal of medicine.
166:419-421.
1997
|
|
| 1996
|
Picture of the month. Polyarteritis nodosa with angioedema..
JAMA Pediatrics.
150:875-876.
1996
|
|
| 1996
|
Picture of the month
1996
|
|
| 1996
|
Reiter syndrome initially misdiagnosed as Kawasaki disease.
Journal of Pediatrics.
128:366-369.
1996
|
|
| 1995
|
The human gp39 promoter: Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation.
Journal of Biological Chemistry.
270:29624-29627.
1995
|
|
| 1995
|
Index of suspicion. Case 2. Diagnosis: peritonsillitis..
Pediatrics in Review.
16:117-119.
1995
|
|
| 1995
|
Necrobacillosis: An unusual cause of purulent otitis media and sepsis.
Pediatric Emergency Care.
11:379-380.
1995
|
|
| 1995
|
Reiter's syndrome associated with cryptosporidial gastroenteritis.
Journal of Rheumatology.
22:1962-1963.
1995
|
|
| 1994
|
Differential effects of T cell receptor ligation of TCRγδ thymocyte development in fetal thymic organ culture.
Thymus.
23:131-153.
1994
|
|
| 1994
|
Scleredema Revisited: A Poststreptococcal Complication.
Clinical Pediatrics.
33:606-610.
1994
|
|
| 1992
|
Peripheral T cell receptor γδ variable gene repertoire maps to the T cell receptor loci and is influenced by positive selection.
Journal of Immunology.
149:3200-3207.
1992
|
|
| 1991
|
Ligand specificity and repertoire development of murine TCRγδ cells.
Current Topics in Microbiology and Immunology.
173:133-139.
1991
|
|
| 1991
|
Repertoire Development and Ligand Specificity of Murine TCRγδ Cells.
Immunological Reviews.
120:5-33.
1991
|
|
| 1990
|
Polymorphisms and diversity of T-cell receptor-γ proteins expressed in mouse spleen.
Immunogenetics.
31:220-228.
1990
|
|
| 1990
|
Freshly isolated Thy-1+ dendritic epidermal cells express T cell receptor γδ-CD3.
Journal of Dermatological Science.
1:459-464.
1990
|
|
| 1990
|
T cell receptor δ-gene expression and diversity in the mouse spleen.
Journal of Immunology.
145:1311-1317.
1990
|
|
| 1989
|
A TCR gamma delta cell recognizing a novel TL-encoded gene product.
1989
|
|
| 1989
|
Identification of distinct T cell receptor (TCR)-γδ heterodimers using an anti-TCR-γ variable region serum.
Journal of Immunology.
143:3769-3775.
1989
|
|
| 1989
|
Phenotypic and functional analysis of murine CD3+, CD4-, CD8- TCR-γδ-expressing peripheral T cells.
Journal of Immunology.
142:3754-3762.
1989
|
|
| 1989
|
Structure and specificity of a class II MHC alloreactive γδ T cell receptor heterodimer.
Science.
245:746-749.
1989
|
|
| 1988
|
Systematic development of distinct T cell receptor-γδ T cell subsets during fetal ontogeny.
Journal of Immunology.
141:3753-3759.
1988
|
|
| 1988
|
Structure and specificity of T cell receptor γ/δ on major histocompatibility complex antigen-specific CD3+, CD4−, CD8− T lymphocytes.
Journal of Experimental Medicine.
168:1899-1916.
1988
|
|
| 1988
|
Peripheral murine CD3+, CD4-, CD8- T lymphocytes express novel T cell receptor gamma delta structures..
Journal of Immunology.
141:1074-1082.
1988
|
|
| 1988
|
Peripheral murine CD3+, CD4-, CD8- T lymphocytes express novel T cell receptor γδ structures.
Journal of Immunology.
141:1074-1082.
1988
|
|
| 1987
|
Major histocompatibility complex-linked specificity of γδ receptor-bearing T lymphocytes.
Nature.
330:262-264.
1987
|
|
